8-K filing — Strata Critical Medical, Inc. (SRTA)
Filed: 2026-08-04 AccNo: 0001628280-26-052152 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
Strata Critical Medical Reports Q2 2026 Results: Full Earnings Call Transcript
On Tuesday, Strata Critical Medical (NASDAQ:SRTA) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 4, 2026, 12:51 PM
- Checked
- Aug 4, 2026, 12:51 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Strata Critical Medical Q2 EPS $(0.12) Misses $(0.02) Estimate, Sales $72.506M Beat $67.112M Estimate
Read original at benzingaStrata Critical Medical Raises FY2026 Sales Guidance from $260.000M-$275.000M to $285.000M-$295.000M vs $275.746M Est
Strata Critical Medical (NASDAQ:SRTA) raises FY2026 sales outlook from $260.000 million-$275.000 million to $285.000 million-$295.000 million vs $275.746 million estimate.
Read original at benzinga